Planning weight maintenance after Mounjaro

What the Mounjaro withdrawal trial tells us

In SURMOUNT-4, adults without diabetes first received tirzepatide for 36 weeks. Those randomised to placebo then gained an average 14.0% from their week-36 weight over the next 52 weeks; those continuing treatment lost a further 5.5%. Lifestyle support continued. [1]

This was a selected group able to reach the randomised phase on 10 or 15 mg. It does not predict what will happen after every dose or treatment duration. Nor does it establish a tapering schedule. The practical lesson is to take the possibility of regain seriously without treating it as a failure of character. Ask your clinician how the evidence applies to your health goals and circumstances.

Make a stopping appointment useful

Explain why you are considering stopping: cost, side effects, pregnancy planning, benefit, supply problems or a change in preference can lead to different conversations. If you also have diabetes, ask who will oversee glucose management. A weight-management plan alone may not cover the reason you originally received Mounjaro.

Bring the date of your last dose, current prescription, recent symptoms and other medicines. Ask for a written plan covering whether treatment should end, any alternative care, when to review and how to get help before then. Do not use leftover pen liquid, smaller unlabelled doses or longer injection gaps as a do-it-yourself bridge. If supply is uncertain, discuss it before the next dose is due.

Prepare for a changing appetite

Review which habits remained easy during treatment and which depended on a very low appetite. A lunch routine that works only when you are never hungry may need changing. Plan accessible meals and a shopping list rather than waiting to discover that the house contains only foods bought for nausea days.

Consider a few practical questions: can you eat at predictable times on workdays, prepare an affordable lunch, and manage social occasions without skipping meals beforehand? Use these to choose one adjustment at a time. If hunger, distress or loss-of-control eating becomes difficult, ask for professional support. Severe restriction to counter a rising scale reading can create another problem rather than solve the first.

Keep movement achievable

NHS advice supports regular activity and strength-building activities at least twice a week, adapted to ability. [2] This is relevant to function and health, but it is not a guarantee of weight or muscle maintenance. Choose something you can repeat in an ordinary week.

Record activities that matter to you: walking to a bus stop, carrying groceries or joining a class. If pain, fatigue or mobility limits what you can do, ask about appropriate adaptations instead of selecting an unrealistic exercise target. A plan with a shorter route for difficult days may be more durable than one that depends on feeling energetic every morning.

Agree how you will respond to change

NHS guidance says support should be offered after weight-loss medicines stop. [3] Ask where that support will come from and whether there is a waiting list. Private prescription supply ending does not automatically arrange an NHS referral, so clarify who is responsible for the next step.

If weighing is helpful, agree a frequency and review trigger with the team. Look at a trend rather than making a treatment decision after one reading. You can also track appetite, energy and daily function. If the plan stops working, bring the information back early. Restarting Mounjaro, switching medicine or choosing another intervention requires a new clinical decision, not a penalty for having regained weight.

Questions and answers